Literature DB >> 25775916

Effectiveness of surgery in liver metastasis from colorectal cancer: experience and results of a continuous improvement process.

F Navarro-Freire1, P Navarro-Sánchez, N García-Agua, B Pérez-Cabrera, A Palomeque-Jiménez, J A Jiménez-Rios, P A García-López, A J García-Ruiz.   

Abstract

PURPOSE: The aim of this study was to estimate the effectiveness of surgery in liver metastasis from colorectal cancer.
METHODS: We conducted a prospective and observational study of patients with colorectal liver metastasis operated on at the San Cecilio University Hospital of Granada from March 2003 until June 2013. The primary variables of the result were survival and morbidity before 30 days of the post-operative period. We also measured preoperative and surgical variables.
RESULTS: A total of 147 patients with liver metastasis of colorectal origin underwent surgical removal during the period of study, 38 of whom had repeat surgery. 34 had a second resection, 3 had a third one and one only patient had a fourth one, for a total of 185 registered operations. The global 5-year survival rate was 38 and 17 % after 10 years. There were 115 patients who had neither radiofrequency nor exploratory laparotomy, 38 % of them survived over 60 months. The average disease-free time was 23.6 months ± 47.3, with significant differences observed between types of procedures. Patients that were operated on just once (n = 25) had a five-year actuarial survival rate of 35 %, a morbidity rate of 24 % and a mortality rate of 0.6 % (1 patient only). The average hospital stay was 13.8 days and the disease-free time was 15.8 months.
CONCLUSION: The results obtained in our surgical unit in terms of morbidity, mortality and five-year actuarial survival rates are comparable to those of other units at large institutions, which are currently considered the standards of quality.

Entities:  

Mesh:

Year:  2015        PMID: 25775916     DOI: 10.1007/s12094-015-1277-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  49 in total

Review 1.  A systematic review of the impact of volume of surgery and specialization on patient outcome.

Authors:  M M Chowdhury; H Dagash; A Pierro
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

2.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

3.  Patient selection for hepatic resection for metastatic colorectal cancer.

Authors:  Matthew J Weiss; Michael I D'Angelica
Journal:  J Gastrointest Oncol       Date:  2012-03

4.  Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect.

Authors:  Dominique Elias; Gabriel Liberale; Déwi Vernerey; Marc Pocard; Michel Ducreux; Valérie Boige; David Malka; Jean-Pierre Pignon; Philippe Lasser
Journal:  Ann Surg Oncol       Date:  2005-09-26       Impact factor: 5.344

5.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.

Authors:  Michael G House; Hiromichi Ito; Mithat Gönen; Yuman Fong; Peter J Allen; Ronald P DeMatteo; Murray F Brennan; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

6.  Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis.

Authors:  Skye C Mayo; Jennifer E Heckman; Andrew D Shore; Hari Nathan; Alexander A Parikh; John F P Bridges; Robert A Anders; Daniel A Anaya; Natasha S Becker; Timothy M Pawlik
Journal:  Surgery       Date:  2011-08       Impact factor: 3.982

7.  Repeat hepatectomy for colorectal liver metastases.

Authors:  R Adam; H Bismuth; D Castaing; F Waechter; F Navarro; A Abascal; P Majno; L Engerran
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

8.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

9.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

Review 10.  Expanding criteria for resectability of colorectal liver metastases.

Authors:  Timothy M Pawlik; Richard D Schulick; Michael A Choti
Journal:  Oncologist       Date:  2008-01
View more
  1 in total

Review 1.  Control of bleeding in surgical procedures: critical appraisal of HEMOPATCH (Sealing Hemostat).

Authors:  Kevin Michael Lewis; Carl Erik Kuntze; Heinz Gulle
Journal:  Med Devices (Auckl)       Date:  2015-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.